Published in HNO on January 01, 2015
[An alternative to percutaneous bone-anchored hearing systems]. HNO (2015) 0.75
Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet (1998) 2.98
Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol (2001) 1.74
The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial. Eur J Cancer (2001) 1.54
Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment. Br J Dermatol (2007) 1.49
[In vivo cochleoscopy through the round window]. HNO (1997) 1.44
Linking disease-associated genes to regulatory networks via promoter organization. Nucleic Acids Res (2005) 1.41
Evidence for active, nonlinear, negative feedback in the vibration response of the apical region of the in-vivo guinea-pig cochlea. Hear Res (2000) 1.41
[Rheologic infusion therapy, neurotransmitter administration and lidocaine injection in tinnitus. A staged therapeutic concept]. HNO (2001) 1.40
Secondary tracheo-oesophageal fistula creation without rigid oesophagoscopy: how we do it. Clin Otolaryngol (2010) 1.39
Role of metal ions in the hydrolysis reaction catalyzed by RNase P RNA from Bacillus subtilis. J Mol Biol (1999) 1.35
TROP2 expression as prognostic marker for gastric carcinoma. J Clin Pathol (2008) 1.32
Thyroid hormone deficiency before the onset of hearing causes irreversible damage to peripheral and central auditory systems. J Neurophysiol (2000) 1.31
Short term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies. Br J Ophthalmol (2004) 1.28
Impact of low-frequency hearing. Audiol Neurootol (2009) 1.27
Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival. Br J Cancer (1995) 1.22
Application of simple chromatographic methods for the diagnosis of defects in pyrimidine degradation. Clin Chem (1993) 1.22
Mechanisms of intraocular photodisruption with picosecond and nanosecond laser pulses. Lasers Surg Med (1994) 1.20
[Application of Optical Coherence Tomography (OCT) in middle ear surgery]. Laryngorhinootologie (2002) 1.13
Normative findings of electrically evoked compound action potential measurements using the neural response telemetry of the Nucleus CI24M cochlear implant system. Audiol Neurootol (2005) 1.12
[Ofloxacin in the conservative therapy of acute and chronic otitis media--a preliminary clinical report of experiences]. Infection (1986) 1.12
Cellular 'neurothekeoma': an epithelioid variant of dermatofibroma? Histopathology (1998) 1.11
A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease. J Crohns Colitis (2010) 1.08
The vibrant soundbridge for conductive and mixed hearing losses: European multicenter study results. Adv Otorhinolaryngol (2010) 1.07
[Contribution to the discussion surrounding the Freiburg speech test]. HNO (2014) 1.06
Clinical experience with the Vibrant Soundbridge implant device. Otol Neurotol (2001) 1.03
Optoacoustic induced vibrations within the inner ear. Opt Express (2009) 1.03
Poliomyelitic-like illness in central European encephalitis. Neurology (2000) 1.02
Factors influencing cochlear implant perceptual performance in 132 adults. Ann Otol Rhinol Laryngol Suppl (1995) 1.02
The German Mouse Clinic: a platform for systemic phenotype analysis of mouse models. Curr Pharm Biotechnol (2009) 1.01
Vascular endothelial growth factor (VEGF) is elevated in brain tumor cysts and correlates with tumor progression. Acta Neuropathol (2000) 1.00
Development of a human three-dimensional organotypic skin-melanoma spheroid model for in vitro drug testing. Cell Death Dis (2013) 1.00
G protein beta 3 gene: structure, promoter, and additional polymorphisms. Hypertension (2000) 0.99
FISH-based detection of 1p 19q codeletion in oligodendroglial tumors: procedures and protocols for neuropathological practice - a publication under the auspices of the Research Committee of the European Confederation of Neuropathological Societies (Euro-CNS). Clin Neuropathol (2011) 0.99
Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis. Neurology (2000) 0.98
[Indication for and verification of hearing aid benefit using modern methods of speech audiometry in German]. HNO (2011) 0.97
[The implementation of risk management in a department of otolaryngology]. Laryngorhinootologie (2011) 0.96
[A novel puncture instrument: the Provox-Vega® puncture set. Its use in voice prosthesis insertion following laryngectomy]. HNO (2013) 0.95
Fibroinflammatory pseudotumor of the temporal bone. Skull Base Surg (1998) 0.95
Progressive multifocal leukoencephalopathy presenting with an isolated focal movement disorder. Mov Disord (2000) 0.95
The fixed combination of collagen with components of fibrin adhesive-a new hemostypic agent in skull base procedures. Skull Base Surg (1997) 0.94
Audiological performance in cochlear implanted patients deafened by meningitis depending on duration of deafness. Eur Arch Otorhinolaryngol (2008) 0.94
Iatrogenic Creutzfeldt-Jakob disease 22 years after human growth hormone therapy: clinical and radiological features. J Neurol Neurosurg Psychiatry (2008) 0.94
Effects of phase duration and pulse rate on loudness and pitch percepts in the first auditory midbrain implant patients: Comparison to cochlear implant and auditory brainstem implant results. Neuroscience (2008) 0.94
Dynamical transition of protein-hydration water. Phys Rev Lett (2010) 0.94
Distinct thyroid hormone-dependent expression of TrKB and p75NGFR in nonneuronal cells during the critical TH-dependent period of the cochlea. J Neurobiol (1999) 0.94
Insertion depth of the Nucleus electrode array and relative performance. Ann Otol Rhinol Laryngol Suppl (1995) 0.94
Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. Radiother Oncol (1999) 0.94
[Salivary duct cyst of the parotid gland and adenocarcinoma]. HNO (1994) 0.93
Suprasellar meningioma with expression of glial fibrillary acidic protein: a peculiar variant. Acta Neuropathol (1995) 0.93
Expression of the histone H3 gene in benign, semi-malignant and malignant lesions of the head and neck: a reliable proliferation marker. Eur J Cancer (1993) 0.93
[Image quality and exposure dose in digital projection radiography]. Rofo (2003) 0.91
Export and transport of tRNA are coupled to a multi-protein complex. Biochem J (2000) 0.91
Dynamics of well-folded and natively disordered proteins in solution: a time-of-flight neutron scattering study. Eur Biophys J (2008) 0.91
Signalling properties of lysophosphatidic acid in primary human skin fibroblasts: role of pertussis toxin-sensitive GTP-binding proteins. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.91
Paediatric cochlear implantation in the first and in the second year of life: a comparative study. Cochlear Implants Int (2004) 0.90
Devic's neuromyelitis optica and Schilder's myelinoclastic diffuse sclerosis. J Neurol Neurosurg Psychiatry (1992) 0.90
Human immunodeficiency virus in vacuolar myelopathy of the acquired immunodeficiency syndrome. N Engl J Med (1988) 0.90
Temporal bone imaging: comparison of flat panel volume CT and multisection CT. AJNR Am J Neuroradiol (2009) 0.89
Immunohistochemical metallothionein expression in colorectal adenocarcinoma: correlation with tumour stage and patient survival. Virchows Arch (1994) 0.89
Deletion mapping on chromosome 17p in medulloblastoma. Br J Cancer (1997) 0.89
Image-guided surgery of the anterior skull base. Acta Otolaryngol (2001) 0.88
Spontaneous increases in impedance following cochlear implantation: suspected causes and management. Int J Audiol (2009) 0.88
Lipoxygenase products in human saliva: patients with oral cancer compared to controls. Free Radic Biol Med (1995) 0.88
Topical treatment with liposomes containing T4 endonuclease V protects human skin in vivo from ultraviolet-induced upregulation of interleukin-10 and tumor necrosis factor-alpha. J Invest Dermatol (2000) 0.88
Coexpression of intermediate filaments in squamous cell carcinomas of upper aerodigestive tract before and after radiation and chemotherapy. Lab Invest (1989) 0.88
[Neonatal hearing screening with the Echosensor automated device for otoacoustic emissions. A comparative study]. HNO (1998) 0.88
Motor performance of women as a function of age and physical activity level. J Gerontol (1986) 0.88
Properties and subcellular localization of CMP-N-acetylneuraminic acid hydrolase of calf kidney. Biochim Biophys Acta (1976) 0.88
Angioneurotic edemas of the upper aerodigestive tract after ACE-inhibitor treatment. Eur Arch Otorhinolaryngol (2002) 0.88
[Parapharyngeal abscess and osteomyelitic destruction of the odontoid process]. Laryngorhinootologie (2006) 0.88
Evidence for transformation-related increase in CTP synthetase activity in situ in human lymphoblastic leukemia. Eur J Biochem (1993) 0.87
Chromogranins as markers of altered hippocampal circuitry in temporal lobe epilepsy. Ann Neurol (2001) 0.87
Effects of the beta3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: relevance to its antidepressant/anxiolytic-like profile. Neuroscience (2008) 0.87
Spectral dips in ion emission emerging from ultrashort laser-driven plasmas. Phys Rev Lett (2004) 0.87
[Tonsillolith: clinical picture and mineralogic analysis]. HNO (1989) 0.87
[Göttingen sentence in noise for different audiogram classes]. Laryngorhinootologie (2012) 0.86
Cellular immune defect caused by postsurgical radiation therapy in patients with head and neck cancer. Otolaryngol Head Neck Surg (1998) 0.86
[Myoepithelial carcinoma of the nasopharynx. Case report and review of the literature]. HNO (1993) 0.86
Place-pitch and speech perception measures with bipolar and monopolar electrical stimulation of the cochlea. Ann Otol Rhinol Laryngol Suppl (1995) 0.86
S-phase fractions and DNA-ploidy of oropharyngeal squamous epithelium carcinomas compared with histologic grade, stage, response to chemotherapy and survival. Acta Otolaryngol (1987) 0.86
Performance and preference for ACE stimulation rates obtained with nucleus RP 8 and freedom system. Ear Hear (2007) 0.86
CMP-N-acetylneuraminic acid hydrolase, an ectoenzyme distributed unevenly over the hepatocyte surface. Biochim Biophys Acta (1977) 0.86
[Peripheral facial palsy as the first symptom of a metastatic bronchogenic carcinoma]. Laryngorhinootologie (2006) 0.86
Pulsed wavelength-dependent laser stimulation of the inner ear. Biomed Tech (Berl) (2012) 0.86
Creutzfeldt-Jakob disease in Austria. J Neurol Neurosurg Psychiatry (1996) 0.86
Ofloxacin in oral chemotherapy of acute and chronic otitis media. Infection (1986) 0.86
Cytokeratin expression and epithelial differentiation in Warthin's tumour and its metaplastic (infarcted) variant. Histopathology (2001) 0.86
Distinct modes of mature and precursor tRNA binding to Escherichia coli RNase P RNA revealed by NAIM analyses. RNA (2001) 0.85
International consensus on meningitis and cochlear implants. Acta Otolaryngol (2005) 0.85
Extensive monitoring during auditory brainstem implant surgery. J Laryngol Otol Suppl (2000) 0.85
[Noninvasive assessment of intracochlear pressure. III. Case reports of patients with intracochlear hyper- and hypotension]. Laryngorhinootologie (1995) 0.85
In vivo experiments in the cat with an implantable piezoelectric hearing aid transducer. Eur Arch Otorhinolaryngol (2000) 0.85
Technical report: modification of a cochlear implant electrode for drug delivery to the inner ear. Otol Neurotol (2003) 0.85
Clinical results and surgical technique for the treatment of extreme lateral lumbar disc herniations: the minimally invasive microscopically assisted percutaneous approach. Zentralbl Neurochir (2008) 0.84
Multicenter audiometric results with the Vibrant Soundbridge, a semi-implantable hearing device for sensorineural hearing impairment. Otolaryngol Clin North Am (2001) 0.84
Glial cell line-derived neurotrophic factor (GDNF) and its receptor (GFR-alpha 1) are strongly expressed in human gliomas. Acta Neuropathol (2000) 0.84
Patterns of p21(waf1/cip1) expression in non-papillomatous nasal mucosa, endophytic sinonasal papillomas, and associated carcinomas. J Clin Pathol (2001) 0.84
Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma. Clin Cancer Res (2001) 0.84